We are developing the next generation of diagnostic and monitoring solutions for people with worsening heart failure.

Intelligent Hemodynamic Monitoring Platform
Proactive Care for People with Heart Failure​

HemoCloud is an intelligent hemodynamic monitoring platform that closely monitors a patient's heart and notifies healthcare professionals when a patient's condition is worsening.

Heart failure (HF) is a global pandemic affecting at least 26 million people worldwide  —  ​5.7 million people in the US  —  and projections in the near future are worrisome. HF health expenditures are considerable and will increase dramatically with an ageing population.

Intelligent Hemodynamic Guidance
Improving Treatment of Worsening Heart Failure​

HemoCath is a novel intelligent medical device that will significantly improve treatment for people with worsening heart failure, like never before.

HemoCath is the next generation of flow-directed pulmonary artery catheters  —  easily inserted in a vein in the upper arm. It provides the two most important measures of fluid status in heart failure patients  —  ​pulmonary artery pressure (PA) and central venous pressure (CVP)  —  simultaneously in real time. 

HemoCath directly monitors PA and CVP continuously over several hours or days  —   allowing more accurate medication dosing  —  potentially improving patient outcomes  —  ​reducing hospitalization and 30-day hospital readmission.